Rhenman & Partners Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-50,000
Closed -$1.23M 109
2016
Q3
$1.23M Sell
50,000
-160,000
-76% -$4.14M 0.2% 86
2016
Q2
$4.23M Buy
210,000
+160,000
+320% +$4.53M 0.75% 55
2016
Q1
$1.31M Sell
50,000
-19,000
-28% -$1.41M 0.26% 84
2015
Q4
$7.01M Buy
+69,000
New +$7.75M 1.06% 39
2015
Q3
Sell
-32,248
Closed -$7.16M 92
2015
Q2
$7.16M Sell
32,248
-3,752
-10% -$832K 0.86% 36
2015
Q1
$7.15M Buy
+36,000
New +$6.39M 1.21% 28

Other funds holding BHC

Rhenman & Partners Asset Management's BHC Position: Q4 2016 in Review

Rhenman & Partners Asset Management sold out of Bausch Health (BHC) in Q4 2016, closing a stake of 50,000 shares — an estimated $1.23M sold.

Rhenman & Partners Asset Management first reported a position in BHC in Q1 2015 and held it in 6 quarters. The position peaked at $7.16M in Q2 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2016.

  • Rhenman & Partners Asset Management reported no remaining Bausch Health position as of Q4 2016 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 50,000 Bausch Health shares in Q4 2016, an estimated $1.23M.
  • Rhenman & Partners Asset Management first reported a position in Bausch Health in Q1 2015 and held it in 6 quarters.
  • Rhenman & Partners Asset Management's Bausch Health position peaked at $7.16M in Q2 2015.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2016.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.